WallStreetZenWallStreetZen

NASDAQ: SBRA
Sabra Health Care Reit Inc Stock

Overview
ForecastEarningsDividendOwnership
$11.50+0.20 (+1.77%)
Updated Mar 31, 2023
SBRA Price
$11.50
Fair Value Price
$11.51
Market Cap
$2.66B
52 Week Low
$10.08
52 Week High
$16.60
P/E
-33.82x
P/B
0.87x
P/S
4.59x
PEG
N/A
Dividend Yield
10.43%
Revenue
$624.81M
Earnings
-$77.61M
Gross Margin
100%
Operating Margin
4.66%
Profit Margin
-12.4%
Debt to Equity
0.88
Operating Cash Flow
$316M
Beta
1.08
Next Earnings
May 2, 2023
Ex-Dividend
N/A
Next Dividend
N/A

SBRA Overview

As of March 31, 2022, Sabra's investment portfolio included 416 real estate properties held for investment. This consists of (i) 279 Skilled Nursing/Transitional Care facilities, (ii) 59 Senior Housing communities (“Senior Housing - Leased”), (iii) 50 Senior Housing communities operated by third-party property managers pursuant to property management agreements (“Senior Housing - Managed”), (iv) 13 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), one asset held for sale, one investment in a sales-type lease, 16 investments in loans receivable (consisting of (i) two mortgage loans, (ii) one construction loan and (iii) 13 other loans), seven preferred equity investments and one investment in an unconsolidated joint venture. As of March 31, 2022, Sabra's real estate properties held for investment included 41,445 beds/units, spread across the United States and Canada.

Zen Score

–
Industry Average (23)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how SBRA scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

SBRA ($11.50) is undervalued by 0.12% relative to our estimate of its Fair Value price of $11.51 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
SBRA ($11.50) is not significantly undervalued (0.12%) relative to our estimate of its Fair Value price of $11.51 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
SBRA is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 35 more SBRA due diligence checks available for Premium users.

Be the first to know about important SBRA news, forecast changes, insider trades & much more!

SBRA News

Valuation

SBRA fair value

Fair Value of SBRA stock based on Discounted Cash Flow (DCF)
Price
$11.50
Fair Value
$11.51
Undervalued by
0.12%
SBRA ($11.50) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
SBRA ($11.50) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
SBRA is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

SBRA price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-33.82x
Industry
29.01x
Market
22.13x

SBRA price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.87x
Industry
1.4x
SBRA is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

SBRA's financial health

Profit margin

Revenue
$165.0M
Net Income
-$84.9M
Profit Margin
-51.5%
SBRA's Earnings (EBIT) of $29.11M... subscribe to Premium to read more.
Interest Coverage Financials
SBRA's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$5.7B
Liabilities
$2.7B
Debt to equity
0.88
SBRA's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
SBRA's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$67.6M
Investing
-$31.2M
Financing
-$13.5M
SBRA's operating cash flow ($315.73M)... subscribe to Premium to read more.
Debt Coverage Financials

SBRA vs Healthcare Facility REIT Stocks

TickerMarket Cap1d %P/EP/B
SBRA$2.66B+1.77%-33.82x0.87x
NHI$2.24B+1.54%34.85x1.76x
HTIA$2.11B-1.40%-22.47x2.12x
CTRE$1.95B+2.25%-244.75x2.29x
DOC$3.55B+0.95%32.46x1.24x
View Top Healthcare Facility REIT Stocks

Sabra Health Care Reit Stock FAQ

What is Sabra Health Care Reit's quote symbol?

NASDAQ: SBRA) Sabra Health Care Reit trades on the NASDAQ under the ticker symbol SBRA. Sabra Health Care Reit stock quotes can also be displayed as NASDAQ: SBRA.

If you're new to stock investing, here's how to buy Sabra Health Care Reit stock.

What is the 52 week high and low for Sabra Health Care Reit (NASDAQ: SBRA)?

(NASDAQ: SBRA) Sabra Health Care Reit's 52-week high was $16.60, and its 52-week low was $10.08. It is currently -30.72% from its 52-week high and 14.09% from its 52-week low.

How much is Sabra Health Care Reit stock worth today?

(NASDAQ: SBRA) Sabra Health Care Reit currently has 231,159,401 outstanding shares. With Sabra Health Care Reit stock trading at $11.50 per share, the total value of Sabra Health Care Reit stock (market capitalization) is $2.66B.

Sabra Health Care Reit stock was originally listed at a price of $171.00 in Apr 2, 2002. If you had invested in Sabra Health Care Reit stock at $171.00, your return over the last 20 years would have been -93.27%, for an annualized return of -12.63% (not including any dividends or dividend reinvestments).

How much is Sabra Health Care Reit's stock price per share?

(NASDAQ: SBRA) Sabra Health Care Reit stock price per share is $11.50 today (as of Mar 31, 2023).

What is Sabra Health Care Reit's Market Cap?

(NASDAQ: SBRA) Sabra Health Care Reit's market cap is $2.66B, as of Apr 1, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Sabra Health Care Reit's market cap is calculated by multiplying SBRA's current stock price of $11.50 by SBRA's total outstanding shares of 231,159,401.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.